Ligand Pharmaceuticals Inc. to Report First Quarter Results on May 2nd
SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today plans to report first quarter 2012 financial results on Wednesday, May 2, 2012. Ligand’s President and CEO, John L. Higgins, Executive Vice President and COO, Matt Foehr and Vice President of Finance and CFO, John Sharp will host the conference call.